Japan Gene Synthesis Research Use Market Size, Share, By Method (Solid-Phase Synthesis, Chip-Based Synthesis, and PCR-Based Enzyme Synthesis), By Application (Vaccine Development, Gene & Cell Therapy Development, and Others), Japan Gene Synthesis Research Use Market Insights, Industry Trend, Forecasts to 2035

Japan Gene Synthesis Research Use Market Insights Forecasts to 2035

• Japan Gene Synthesis Research Use Market Size 2024: USD 181.5Mn
• Japan Gene Synthesis Research Use Market Size 2035:  USD 1073.7Mn
• Japan Gene Synthesis Research Use Market CAGR 2024: 17.54%
• Japan Gene Synthesis Research Use Market Segments: Method and Application

The Japan Gene Synthesis Research Use Market Size is the term used to describe the market for synthetic genes, which are prepared according to the specifications of the users, and are primarily employed in academic, pharmaceutical, and biotechnology research for understanding the gene’s role, disease-related processes, and drug development.

Strategic alliances in mRNA & cell therapy: A rising number of companies are making alliances domestically in order to get next-gen medicine's supply chains. FUJIFILM Toyama Chemical and Synplogen partnership, which was formed in April of the year 2024, will provide a complete range of CDMO services for mRNA therapeutics from sequence design to fill-and-finish.

The government has also provided large-scale funding (billions of yen, for instance) in the area of regenerative medicine, cell, and gene therapy manufacturing and infrastructure, which is another factor that makes Japan a strong competitor in the biopharma market that heavily relies on gene synthesis technologies.

Among the future opportunities, the demand for gene and cell therapy research, vaccine development, synthetic biology, AI-based drug discovery, and advanced life-science innovation with increased government funding are going to be the major contributors.

Market Dynamics of the Japan Gene Synthesis Research Use Market:

The Japan Gene Synthesis Research Use Market Size is driven by the increasing investments made in genomics and synthetic biology research, high government support for life sciences, the rising development of gene and cell therapies, the growing R&D of vaccines, as well as the growing need of academic institutes and biotechnology firms for precise and tailored DNA synthesis solutions.

The Japan Gene Synthesis Research Use Market Size is restrained by the costs for advanced gene synthesis, biosecurity and regulatory requirements that are quite strict, long approval timelines, shortage of skilled workforce, and ethical issues regarding genetic engineering research are some of the factors that are limiting the growth of the market.

The future of Japan's Gene Synthesis Research Use Market Size is bright and promising, with increasing investments in genomics, the flourishing of gene and cell therapy research, the expansion of vaccine development, the continuous innovation of technology, and the government providing strong support for life-science innovation.

Market Segmentation

The Japan gene synthesis research use market share is classified into method and application.

By Method:

The Japan Gene Synthesis Research Use Market Size is divided by method into solid-phase synthesis, chip-based synthesis, and PCR-based enzyme synthesis. Among these, the PCR-based Enzyme Synthesis segment dominated the share in 2024 and is anticipated to grow at a remarkable CAGR during the forecast period. The gene construction of flexible, medium-length genes has been widely adopted in both academic and industrial markets. Thus, PCR-based enzyme synthesis is dominated by faster turnaround, high accuracy, and cost-effectiveness.

By Application:

The Japan Gene Synthesis Research Use Market Size is divided by application into vaccine development, gene & cell therapy development, and others. Among these, the gene & cell therapy development segment accounted for the largest market share in 2024 and is anticipated to grow at a remarkable CAGR during the forecast period. The development of gene and cell therapy is still on top, owing to the increasing regenerative medicine research and development, personalized therapies, strong academic-industry collaboration, and the high demand for custom gene constructs in the cutting-edge biomedical research area.

Competitive Analysis:

The report offers the appropriate analysis of the key organisations/companies involved within the Japan Gene Synthesis Research Use Market Size, along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market. 

Top Key Companies in Japan Gene Synthesis Research Use Market:

• Takara Bio Inc.
• Synplogen Co., Ltd.
• FASMAC Co., Ltd.
• Rocio Genomics
• Eurofins Genomics Japan
• Medical & Biological Laboratories (MBL)
• Repro CELL
• Pt Bio Inc.
• Peptic Dream
• Others

Key Target Audience

• Market Players
• Investors
• End-users
• Government Authorities 
• Consulting and Research Firm
• Venture capitalists
• Value-Added Resellers (VARs)

Market Segment

This study forecasts revenue at the Japan, regional, and country levels from 2020 to 2035. Spherical Insights has segmented the Japan gene synthesis research use market based on the below-mentioned segments:

Japan Gene Synthesis Research Use Market, By Method

• Solid-phase Synthesis
• Chip-based Synthesis
• PCR-based Enzyme Synthesis

Japan Gene Synthesis Research Use Market, By Application

• Vaccine Development
• Others
• Gene & Cell Therapy Development